The company publishes a clinical study that examines the positive effects of the formula on women with premenstrual syndrome (PMS) The results show that women who take the formula demonstrate [...]
Following successful formula safety and efficacy studies, Lipogen receives the European Union’s most prestigious safety certificate NOVEL FOOD. This extensive approval process includes submitting [...]
Lipogen publishes results of the clinical trial that assesses the effects of the formula on people’s cortisol stress hormone levels. There is large and growing evidence worldwide about the [...]
Lipogen formulas are designated Generally Recognized As Safe (GRAS) by the FDA. To obtain this approval, companies must prepare a comprehensive product safety portfolio, including a detailed [...]
Lipogen conducts an independent clinical study examining the effects of the Lipogen PSPA formula on the stress hormone cortisol. When the level of cortisol in the body remains abnormally high, [...]
The US Food and Drug Administration (FDA) grants the primary Lipogen ingredient phosphatidylserine (PS) a Qualified Health Claim approval, allowing Lipogen to specify on its label that [...]
The company conducts a clinical study that shows significant positive impact of the Lipogen PS Plus formula on Alzheimer’s disease patients’ daily functioning, emotional state and general [...]
Lipogen builds upon the Weizmann Institute’s research success, progressing to formal formula development and clinical research. Lipogen demonstrates the positive effects of the Lipogen PSPA [...]
Lipogen established as partnership between company founders and two pioneering scientists – Professor Meir Shinitzky and Dr. Avner Sheinfeld –from the renowned Weizmann Institute. Lipogen [...]
